These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1680224)

  • 1. Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path.
    Ylinen A; Valjakka A; Lahtinen H; Miettinen R; Freund TF; Riekkinen P
    Neuropeptides; 1991 Jul; 19(3):205-11. PubMed ID: 1680224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine potentiates entorhinal activation of dentate gyrus granule cells in rats.
    Takazawa A; Abraham WC; Sekino Y
    Brain Res Bull; 1994; 33(4):437-43. PubMed ID: 7907266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
    Jolkkonen J; Mazurkiewicz M; Lahtinen H; Riekkinen P
    Eur J Pharmacol; 1992 Dec; 229(2-3):269-72. PubMed ID: 1490526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM; Armijo JA
    Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of perforant path neurons to field CA1 by hippocampal projections.
    Bartesaghi R; Gessi T
    Hippocampus; 2003; 13(2):235-49. PubMed ID: 12699331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor.
    Gibson JP; Yarrington JT; Loudy DE; Gerbig CG; Hurst GH; Newberne JW
    Toxicol Pathol; 1990; 18(2):225-38. PubMed ID: 2399411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies of the influence of vigabatrin on the GABA system.
    Gram L; Larsson OM; Johnsen A; Schousboe A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):13S-17S. PubMed ID: 2757904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy.
    Sloviter RS
    Hippocampus; 1991 Jan; 1(1):41-66. PubMed ID: 1688284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hilar somatostatin interneuron loss reduces dentate gyrus inhibition in a mouse model of temporal lobe epilepsy.
    Hofmann G; Balgooyen L; Mattis J; Deisseroth K; Buckmaster PS
    Epilepsia; 2016 Jun; 57(6):977-83. PubMed ID: 27030321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin neurons are a subpopulation of GABA neurons in the rat dentate gyrus: evidence from colocalization of pre-prosomatostatin and glutamate decarboxylase messenger RNAs.
    Esclapez M; Houser CR
    Neuroscience; 1995 Jan; 64(2):339-55. PubMed ID: 7700525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of dentate hilar neurons by stimulation of the fimbria in rat hippocampal slices.
    Scharfman HE
    Neurosci Lett; 1993 Jun; 156(1-2):61-6. PubMed ID: 8105429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The perforant path projection from the medial entorhinal cortex layer III to the subiculum in the rat combined hippocampal-entorhinal cortex slice.
    Behr J; Gloveli T; Heinemann U
    Eur J Neurosci; 1998 Mar; 10(3):1011-8. PubMed ID: 9753168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive feedback from hilar mossy cells to granule cells in the dentate gyrus revealed by voltage-sensitive dye and microelectrode recording.
    Jackson MB; Scharfman HE
    J Neurophysiol; 1996 Jul; 76(1):601-16. PubMed ID: 8836247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of vigabatrin.
    Sabers A; Gram L
    Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression by sodium valproate of gamma-vinyl GABA-induced facilitation of visual evoked potentials in rats.
    Myslobodsky MS; Morag M
    Electroencephalogr Clin Neurophysiol; 1981 Nov; 52(5):445-50. PubMed ID: 6171410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the medial septal area attenuates LTP of the lateral perforant path and enhances heterosynaptic LTD of the medial perforant path in aged rats.
    Pang K; Williams MJ; Olton DS
    Brain Res; 1993 Dec; 632(1-2):150-60. PubMed ID: 8149224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced but fragile inhibition in the dentate gyrus in vivo in the kainic acid model of temporal lobe epilepsy: a study using current source density analysis.
    Wu K; Leung LS
    Neuroscience; 2001; 104(2):379-96. PubMed ID: 11377842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala.
    Pitkänen A; Tuunanen J; Halonen T
    Epilepsy Res; 1996 May; 24(1):29-45. PubMed ID: 8800633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug.
    Rimmer E; Kongola G; Richens A
    Br J Clin Pharmacol; 1988 Feb; 25(2):251-9. PubMed ID: 3358887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.